Private
The Phase 3 SIMPLE trial of Gilead Sciences Inc’s antiviral drug remdesivir has reached its primary endpoint, supplying positive data that COVID-19 patients administered the drug early fared better than those treated later.
From 397 patients, the study revealed that 62 percent of patients... Read More »
The Cerus Corporation has created the INTERCEPT Blood System as a means to reduce pathogens in red blood cells, and now, the Biomedical Advanced Research and Development Authority (BARDA) is collaborating with it to test the system’s capabilities against SARS-CoV-2.
SARS-CoV-2 is the virus... Read More »
The Bipartisan Commission on Biodefense is poised to assist a national COVID-19 commission that would be created under legislation introduced earlier this month.
Specifically, recommendations and pandemic plans issued by the Bipartisan Commission on Biodefense would be reviewed and evaluated by... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) will invest $3.5 million in Clover Biopharmaceuticals Australia to develop a COVID-19 vaccine.
It is CEPIʻs ninth investment in a COVID-19 vaccine. The investments total $39.6 million.
This latest investment will support Clover... Read More »
Professional services and technology firm KBR has secured a $63.9 million Department of Defense (DoD) task order to develop interoperability solutions resulting in expanded military testing and training capabilities.
KBR’s scope of work on the DoD’s Test Resource Management Center (TRMC)... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) announced two partnerships this week in its ongoing fight against COVID-19: America’s Blood Centers, to help collect and distribute convalescent plasma, and InBios International, Inc. to hasten the development of serological... Read More »
Boeing recently completed another COVID-19 transport mission resulting in 1.5 million medical-grade face masks reaching healthcare professionals at Prisma Health in South Carolina.
The Boeing Dreamlifter delivered personal protective equipment (PPE) from Hong Kong in partnership with Prisma... Read More »
Northern Arizona University (NAU) researchers staffing the Pathogen and Microbiome Institute (PMI) have launched the COVID-19 Testing Service Center (CTSC) to grow the SARS-CoV-2 virus and test drugs against it.
"The COVID-19 pandemic is a crisis that requires the whole scientific community... Read More »
An Oxford University vaccine for COVID-19 funded by the Coalition for Epidemic Preparedness Innovations (CEPI) last month has officially advanced into Phase 1 testing, complete with human trials.
Known as ChAdOx1 nCoV-19, the candidate is the third CEPI-funded vaccine to enter Phase 1 trials.... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) has struck a partnership with Cytovale to develop a rapid diagnostic system for sepsis as part of the COVID-19 pandemic response.
Cytovale’s rapid diagnostic system analyzes the biomechanical properties of immune cells, which... Read More »
Emergent BioSolutions Inc. said on Thursday it will provide contract development and manufacturing organization (CDMO) services to support Johnson & Johnson’s efforts to develop a vaccine candidate for COVID-19.
The vaccine candidate leverages the AdVac and PER.C6 technologies from the Janssen... Read More »
New York State and Bloomberg Philanthropies are working together on a contact tracing initiative to control the infection rate of COVID-19.
Bloomberg Philanthropies, founded by Mike Bloomberg, has committed $10.5 million, along with organizational support and technical assistance, to build out... Read More »
In a new report titled Developing a National Strategy for Serology in the United States, the Johns Hopkins Center for Health Security argued for the creation of a national antibody testing strategy in the United States to counteract the spread of COVID-19.
One of the major problems for the U.S.... Read More »
The spread of coronavirus in the United States has unveiled various levels of inequalities in society, including between major cities with more robust hospital systems and rural communities with less access to resources.
The COVID-19: A Frontline Guide for Local Decision-Makers, a global... Read More »
Pharmaceutical firm Roche said it has developed and would soon launch its test detecting antibodies in people exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes COVID-19.
The Elecsys Anti-SARS-CoV-2 serology test can support priority screening of high-risk... Read More »
Department of Justice officials recently forwarded a Business Review Letter to AmerisourceBergen, notifying the firm there would be no challenge to efforts to aid COVID-19 treatment efforts.
“We commend AmerisourceBergen’s efforts to assist the United States in responding to the COVID-19... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Tangen Biosciences, Inc. are teaming up to develop a rapid diagnostic test for SARS-CoV-2, capable of producing results within an hour.
The test will be paired with the Tangen GeneSpark, a molecular diagnostic system, and... Read More »
Novartis is proceeding with a Phase III clinical trial to evaluate the use of hydroxychloroquine for the treatment of patients with COVID-19 disease.
The company got the go-ahead from the US Food and Drug Administration (FDA). The trial will involve approximately 440 patients and be conducted at... Read More »
National Institute of Standards and Technology (NIST) researchers said they have developed a tool designed to aid hospitals and medical professionals in disinfecting N95 masks.
In the wake of hospitals nationwide disinfecting N95 masks by placing them in repurposed rooms or shipping containers... Read More »
Animal testing of the Gilead Sciences Inc.-created antiviral Remdesivir showed promise against rhesus macaques infected with SARS-CoV-2, the virus responsible for COVID-19, National Institutes of Health (NIH) scientists said.
This study was led by the NIH’s National Institute of Allergy and... Read More »
A universal Ebola vaccine may fight all four virus species that infect humans, according to preclinical tests of a new treatment at the Cincinnati Children’s Hospital Medical Center.
Data published in the Journal of Virology shows the virus could work as a stand-alone protection, but may also... Read More »
In a teleconference between experts from the Immunization Action Coalition, FasterCures and the U.S. Food and Drug Administration (FDA) on Friday, one thing was made abundantly clear: the world needs the best possible vaccines to combat COVID-19 as quickly as possible.
In the opinion of Dr.... Read More »
The Biomedical Advanced Research Development Authority (BARDA) is working with Hememics Biotechnologies to develop a rapid antigen and antibody test to identify the COVID-19 coronavirus in 60 seconds.
The test will be designed to detect the SARS-CoV-2 antigen, which causes COVID-19, from nasal... Read More »
The U.S. Food and Drug Administration (FDA) announced that a recent collaboration including U.S. Cotton, UnitedHealth Group, Quantigen, and the Gates Foundation has resulted in further COVID-19 testing option expansion.
Officials said the determination that spun synthetic swabs, with a design... Read More »
Invoking the Defense Production Act (DPA), the Department of Health and Human Services (HHS) has entered a new, $336 million contract with General Electric (GE) that will see 50,000 ventilators supplied to the government by July 13.
"The President promised on March 27 that we would have 100,000... Read More »
Moderna is working toward U.S. Food and Drug Administration (FDA) licensure on an mRNA vaccine for SARS-CoV-2 -- the virus that causes COVID-19 -- with a $483 million award from the Biomedical Advanced Research and Development Authority (BARDA).
“Vaccines are a critical tool for saving lives... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) is partnering with the American Red Cross (ARC) to recruit blood donors who have recovered from COVID-19.
BARDA and the ARC are working with the U.S. Food and Drug Administration (FDA) to collect convalescent plasma for use as a... Read More »
National Institutes of Health (NIH) scientists maintain N95 respirators can maintain functional integrity for up to three uses when decontaminated effectively.
The findings stem from a study conducted in a controlled laboratory setting. The results are not yet peer-reviewed but are being shared... Read More »
Harried by an ongoing shortage of personal protective equipment for some of the emergency responders who need it most amid the COVID-19 pandemic -- firefighters and EMS workers -- the International Association of Fire Chiefs (IAFC) is pitching a survey they hope to present directly to President... Read More »
Efforts begun on a SARS-CoV-2 vaccine in February are moving closer to fruition for the Biomedical Advanced Research and Development Authority (BARDA) and Sanofi Pasteur, with the announcement of pending non-clinical studies and a Phase 1 clinical trial.
These trials will determine the initial... Read More »
Millions of N95 respirators used by U.S. health care workers in hospital settings can now be sterilized for reuse, helping to combat the spread of COVID-19.
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) on April 11 for one such technology that has the... Read More »
Researchers and engineers from the University of Illinois at Urbana-Champaign and Carle Health launched an effort to produce face shields for health professionals responding to the COVID-19 pandemic.
It stems from a personal protective equipment (PPE) design initiative led by The Grainger... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) is working with Vela Diagnostics USA to develop a rapid diagnostic test for the COVID-19 pandemic.
The rapid diagnostic test would be for use on two instrument platforms, which is needed to test as many people as possible and... Read More »
Ohio State University researchers have received Food and Drug Administration (FDA) approval for a process designed to expand and accelerate COVID-19 testing statewide.
In response to shortages of test kit components, including swabs and vials filled with a liquid called viral transport media... Read More »
The push for convalescent plasma and hyperimmune globulin immunotherapies to use against COVID-19 continues at the federal level, with the U.S. Department of Health and Human Services (HHS) touting collaboration with non-governmental entities to see it done.
These immunotherapies could... Read More »
